Skip to main content
Premium Trial:

Request an Annual Quote

Cleaning up Medical Research

In an essay published in PLOS Medicine, John Ioannidis, a professor of medicine and of health research and policy at Stanford University, proposes a few modifications to current medical research practices that he believes will improve the accuracy of published results and cut down on wasted resources.

"Currently, major decisions about how research is done may too often be based on convention and inertia rather than being highly imaginative or evidence-based," he writes. "For example, there is evidence that grant reviewers typically have only modest CVs and most of the top influential scientists don't review grant applications and don't get funded by government funds, even in the United States."

"Non-meritocratic practices, including nepotism, sexism, and unwarranted conservatism, are probably widespread," he adds. "Allegiance and confirmation biases are powerful in scientific processes. For healthcare and clinical practice, while evidence-based medicine has grown stronger over time, some argue that it is currently in crisis and 'evidence-based' terminology has been usurped to promote expert-based beliefs and industry agendas."

The piece, which coincides with PLOS Medicine's 10th anniversary, is a response to issues concerning the medical research enterprise that he first raised in 2005, arguing that "most published research findings are false" and discussed the implications of his claim.

In his latest essay, Ioannidis suggests transplanting practices that have improved "credibility and efficiency" in other fields, for example, "adopting large-scale collaborative research; replication culture; registration; sharing; reproducibility practices; [and] better statistical methods," among others. Figuring out which of these interventions would best improve research practice "requires rigorous examination and experimental testing whenever feasible" and should "understand and harness the motives of various stakeholders," he writes.

He also argues that the current reward system and its associated "currencies" — publications, grants, promotions, and so on — needs to be modified in ways that are "better aligned with translatable and reproducible research."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.